FR2383184A1 - Procede de preparation d'ethers - Google Patents

Procede de preparation d'ethers

Info

Publication number
FR2383184A1
FR2383184A1 FR7806294A FR7806294A FR2383184A1 FR 2383184 A1 FR2383184 A1 FR 2383184A1 FR 7806294 A FR7806294 A FR 7806294A FR 7806294 A FR7806294 A FR 7806294A FR 2383184 A1 FR2383184 A1 FR 2383184A1
Authority
FR
France
Prior art keywords
clavulanic
ethers
formula
group
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7806294A
Other languages
English (en)
French (fr)
Other versions
FR2383184B1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB10082/77A external-priority patent/GB1582864A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2383184A1 publication Critical patent/FR2383184A1/fr
Application granted granted Critical
Publication of FR2383184B1 publication Critical patent/FR2383184B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7806294A 1977-03-10 1978-03-06 Procede de preparation d'ethers Granted FR2383184A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1011677 1977-03-10
GB10082/77A GB1582864A (en) 1977-03-10 1977-03-10 Chemical process for the preparation of clavulanic acid derivatives

Publications (2)

Publication Number Publication Date
FR2383184A1 true FR2383184A1 (fr) 1978-10-06
FR2383184B1 FR2383184B1 (es) 1980-08-29

Family

ID=26247246

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7806294A Granted FR2383184A1 (fr) 1977-03-10 1978-03-06 Procede de preparation d'ethers

Country Status (19)

Country Link
JP (1) JPS53112894A (es)
AR (1) AR216505A1 (es)
AT (1) AT359188B (es)
AU (1) AU519232B2 (es)
CH (1) CH632760A5 (es)
DE (1) DE2808116A1 (es)
DK (1) DK139377A (es)
ES (1) ES467513A1 (es)
FI (1) FI65252C (es)
FR (1) FR2383184A1 (es)
GR (1) GR64160B (es)
HK (1) HK15084A (es)
IE (1) IE46478B1 (es)
IL (1) IL54078A0 (es)
KE (1) KE3337A (es)
MX (1) MX4864E (es)
NL (1) NL7802596A (es)
NO (1) NO771106L (es)
SE (1) SE442748B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862254D1 (en) * 1977-12-02 1983-06-16 Beecham Group Plc A process for the preparation of ether derivatives of clavulanic acid
JPS58187371A (ja) * 1982-04-27 1983-11-01 Nec Corp 印字濃度制御回路
DE3725375A1 (de) * 1987-07-31 1989-02-09 Bayer Ag Stabile oxapenem-3-carbonsaeuren

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2335222A1 (fr) * 1975-12-17 1977-07-15 Glaxo Lab Ltd Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2335222A1 (fr) * 1975-12-17 1977-07-15 Glaxo Lab Ltd Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV6015C/69 *

Also Published As

Publication number Publication date
IE780477L (en) 1978-09-10
SE7704085L (sv) 1978-09-11
KE3337A (en) 1983-11-25
ATA145178A (de) 1980-03-15
AU519232B2 (en) 1981-11-19
FR2383184B1 (es) 1980-08-29
NL7802596A (nl) 1978-09-12
DE2808116A1 (de) 1978-09-21
CH632760A5 (en) 1982-10-29
DK139377A (da) 1978-09-11
FI771146A (fi) 1978-09-11
ES467513A1 (es) 1979-08-01
IL54078A0 (en) 1978-04-30
AT359188B (de) 1980-10-27
JPS53112894A (en) 1978-10-02
HK15084A (en) 1984-02-24
NO771106L (no) 1978-09-12
SE442748B (sv) 1986-01-27
MX4864E (es) 1982-11-10
IE46478B1 (en) 1983-06-29
FI65252C (fi) 1984-04-10
FI65252B (fi) 1983-12-30
AR216505A1 (es) 1979-12-28
AU3384078A (en) 1979-09-06
GR64160B (en) 1980-02-05

Similar Documents

Publication Publication Date Title
RO77559A (ro) Procedeu de preparare a eritro-9-(2-hidroxi-3-alchil)hidroxantinei
GB1490603A (en) Glycerides with anti-inflammatory properties
FR2355796A1 (fr) Procede de preparation de fluorures d'acides perfluoro-alcoxy-propioniques
FR2383184A1 (fr) Procede de preparation d'ethers
PL206644A1 (pl) Sposob wytwarzania podstawionych estrow benzylowych kwasow winylocyklopropanokarboksylowych
ES8106693A1 (es) Un procedimiento para preparar nuevos esteres carboxilicos de propiedades insecticidas
GB2017087A (en) Process for the preparation of xanthone derivatives
ES325261A1 (es) Procedimiento para la produccion de esteroides.
ES8206535A1 (es) Un metodo mejorado para producir un compuesto de 7-aminoce- fem.
ES8307236A1 (es) Un procedimiento para la preparacion de ranitidina.
FR2401911A1 (fr) Procede de preparation de 2-chlorosulfinylazetidin-4-ones
FR2359133A1 (fr) Procede de preparation de (vinyl 2,2-disubstitue)-g-butyrolactones
ES468143A1 (es) Procedimiento para la obtencion de esteres de acido fosfori-co perfluoralquilsustituidos.
FR2385723A1 (fr) Procede d'epimerisation d'une thiazolidine-azetidinone
EG14458A (en) Branched salkyl phosphonodithioic halide intermediates and process for their production
FR2453159A1 (fr) Procede de preparation de 2-aminopyrazines substituees
SE7900889L (sv) Sett att framstella xantonderivat
ES8206522A1 (es) Un procedimiento para la preparacion de esteres del acido apovincaminico racemico u opticamente activos
ES464851A1 (es) Procedimiento para la preparacion de derivados de acidos 3- carboxifenilaceticos.
FR2367770A1 (fr) Procede de preparation d'acides alcenylphosphiniques
FR2373549A1 (fr) Procede de transformation de 3-methylenecephalosporines en 3-heterothiomethylcephalosporines
FR2453160A1 (fr) Procede de preparation de quinazolinones
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona
ES8107225A1 (es) Procedimiento para la obtencion de nuevas penicilinas
ES468766A1 (es) Procedimiento para preparar acetanilidas

Legal Events

Date Code Title Description
ST Notification of lapse